Targeting MDR1-P-glycoprotein (MDR1-Pgp) in immunochemotherapy of acute myeloid leukemia (AML)

• Yazar: Maurizio Cianfriglia (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Istituto Superiore di Sanità, 2013-06-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

BACKGROUND: Monoclonal antibodies represent the fastest growing sector of pharmaceutical biotechnology and a number of antibody-based biopharmaceuticals have been approved for cancer treatment. However, in many cases the antibodies used for the treatment of tumors offer only a modest survival benefi...